18411057. COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME simplified abstract (FUJIFILM Corporation)

From WikiPatents
Jump to navigation Jump to search

COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME

Organization Name

FUJIFILM Corporation

Inventor(s)

Kenji Shirokane of Kanagawa (JP)

Yuji Yoshimitsu of Kanagawa (JP)

Naoka Hamada of Kanagawa (JP)

Yoshinori Kanazawa of Kanagawa (JP)

Hiroaki Tanaka of Kanagawa (JP)

COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME - A simplified explanation of the abstract

This abstract first appeared for US patent application 18411057 titled 'COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME

Simplified Explanation

The patent application describes a compound with multiple phosphor moieties that have equivalent light absorption characteristics, linked through a specific structure, and used to label biological substances.

  • Compound with multiple phosphor moieties
  • Phosphor moieties have equivalent light absorption characteristics
  • Moieties are linked through a specific structure
  • Used to label biological substances

Potential Applications

The technology could be used in various fields such as:

  • Biological research
  • Medical diagnostics
  • Drug development

Problems Solved

This technology addresses issues such as:

  • Improving labeling efficiency
  • Enhancing detection sensitivity
  • Increasing accuracy in biological assays

Benefits

The benefits of this technology include:

  • Improved accuracy in biological labeling
  • Enhanced detection capabilities
  • Potential for new discoveries in biological research

Potential Commercial Applications

The technology could have commercial applications in:

  • Biotechnology companies
  • Pharmaceutical companies
  • Research institutions

Possible Prior Art

Prior art in this field may include:

  • Existing compounds for biological labeling
  • Technologies for enhancing detection sensitivity

Unanswered Questions

How cost-effective is the production of this compound compared to existing labeling methods?

The cost-effectiveness of producing this compound compared to other labeling methods is not addressed in the abstract. Further research or data may be needed to determine this aspect.

What specific biological substances have been successfully labeled using this compound?

The abstract does not specify the biological substances that have been labeled using this compound. Additional information or studies may be required to identify the specific applications of this technology.


Original Abstract Submitted

There are provided a compound having two or more phosphor moieties of which light absorption characteristics are equivalent to each other, in which the phosphor moieties adjacent to each other are each linked through a group including a structure represented by General Formula (I), and a labeled biological substance using the compound.